Back
NVIDIA Corp. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Buy
57
NVDA
NVIDIA Corp.
Last Price:
$187.54
Seasonality Move:
18.18%
Buy
67
KYMR
Kymera Therapeutics, Inc.
Last Price:
$78.09
Seasonality Move:
-9.68%
Buy
57
NVIDIA Corp. (NVDA)
is a Buy
Is NVIDIA Corp. a Buy, Sell or Hold?
-
The current NVIDIA Corp. [NVDA] share price is $188.22. The Score for NVDA is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
NVDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $80.35. The Score for KYMR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVDA Stock Price Chart
What is NVIDIA Corp.'s stock price today?
-
The NVIDIA Corp. share price today is $188.22Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVDA is experiencing slight selling pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $80.35The current trend is moderately bearish and KYMR is experiencing slight selling pressure.
NVDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.69 | Buy |
| Relative Strength Index (14 RSI): | 55.68 | Buy |
| Chaikin Money Flow: | 74871997 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.03 | Buy |
| Relative Strength Index (14 RSI): | 54.68 | Buy |
| Chaikin Money Flow: | -224422 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
NVDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 183.29 | Buy |
| 20-day SMA: | 181.87 | Buy |
| 50-day SMA: | 186.19 | Buy |
| 200-day SMA: | 159.46 | Buy |
| 8-day EMA: | 185.42 | Buy |
| 20-day EMA: | 183.39 | Buy |
| 50-day EMA: | 183.43 | Buy |
| 200-day EMA: | 165.56 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 82.3 | Sell |
| 20-day SMA: | 80.34 | Buy |
| 50-day SMA: | 69.42 | Buy |
| 200-day SMA: | 47.86 | Buy |
| 8-day EMA: | 82.24 | Sell |
| 20-day EMA: | 79.61 | Buy |
| 50-day EMA: | 71.43 | Buy |
| 200-day EMA: | 53.99 | Buy |
NVIDIA Corp. Earnings Growth & NVDA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.27 per share, an increase next quarter of $0.20 per share, an increase this year of $1.74 per share, and an increase next year of $2.87 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.36 per share.
NVIDIA Corp. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||